Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital.

Yu K, Westbrook M, Brodie S, Lisker S, Vittinghoff E, Hua V, Russell M, Sarkar U

OTO Open 2020 Feb doi: 10.1177/2473974X19900761

Physician and Patient Adjustment to Reference Pricing for Drugs.

Robinson JC, Whaley C, Brown TT, Dhruva SS

JAMA Netw Open 2020 Feb doi: 10.1001/jamanetworkopen.2019.20544

Electronic Health Record Time Among Outpatient Physicians: Reflections on the Who, What, and Why.

By:

Ann Intern Med 2020 Feb doi: 10.7326/M19-3921

Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.

Wang W, Su Y, Wu C, Sun Y, Dai N, Chen W, Zhang J, Xu Y, Brindis RG, Xu D, Li J

BMC Cardiovasc Disord 2020 Feb doi: 10.1186/s12872-020-01345-z

Feasibility of implementing mobile technology-delivered mental health treatment in routine adult sickle cell disease care.

Jonassaint CR, Kang C, Prussien KV, Yarboi J, Sanger MS, Wilson JD, De Castro L, Shah N, Sarkar U

Transl Behav Med 2020 Feb doi: 10.1093/tbm/iby107

CE: An Evidence-Based Update on Contraception.

Britton LE, Alspaugh A, Greene MZ, McLemore MR

Am J Nurs 2020 Feb doi: 10.1097/01.NAJ.0000654304.29632.a7

Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).

Trosman JR, Weldon CB, Slavotinek A, Norton ME, Douglas MP, Phillips KA

Genet Med 2020 Feb doi: 10.1038/s41436-019-0650-7

The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.

Friend BD, Bailey-Olson M, Melton A, Shimano KA, Kharbanda S, Higham C, Winestone LE, Huang J, Stieglitz E, Dvorak CC

Pediatr Blood Cancer 2020 Feb doi: 10.1002/pbc.28079

Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices.

Bansback N, Curtis JR, Huang J, He Z, Evans M, Johansson T, Michaud K, Schmajuk G, Liao KP

ACR Open Rheumatol 2020 Feb doi: 10.1002/acr2.11106

RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.

Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schlünssen V, Sgargi D, Silbergeld EK, Sørensen K, Sutton P, Tenkate T, Torreão Corrêa da Silva D, Ujita Y, van Deventer E, Woodruff TJ, Mandrioli D

Environ Int 2020 Feb doi: 10.1016/j.envint.2019.105039